Should You Buy IF Bancorp Inc (IROQ) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/29
IROQ is not a good buy right now for an impatient buyer. Fundamentals are improving sharply, but the current tape doesn’t offer a strong momentum entry (MACD weakening, price sitting just below the pivot with limited immediate upside to resistance). I would hold/watch rather than buy at 27.26 today; a better buy would be on a decisive push back above ~27.40–27.75 with improving momentum.
Technical Analysis
Trend/structure: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports an overall uptrend. Momentum: MACD histogram is negative (-0.0102) and expanding lower, signaling fading short-term momentum despite the bullish MA stack. RSI(6) ~49.9 is neutral (no overbought/oversold edge).
Key levels: Current 27.26 is below Pivot 27.399 (slightly bearish/indecisive near-term). Support: S1 27.052 then S2 26.837. Resistance: R1 27.747 then R2 27.962. The setup looks range-bound unless price reclaims the pivot and breaks R1.
Pattern-based forecast: Similar-pattern read suggests modest upside bias (next day ~+0.45%, next week ~+3.25%, next month ~+5.25%), but this is not confirmed by momentum indicators today.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
No analyst rating or price-target change data was provided, suggesting limited/absent recent Wall Street coverage updates. Wall Street-style pros: sharp YoY earnings and net income growth; trend support from bullish moving averages. Cons: no visibility on valuation metrics/targets here, and the current technical momentum is weakening, reducing confidence in an immediate buy-now entry.
Politicians/influential figures: No recent congress trading data available in the last 90 days (no signal of political buying/selling pressure).
Wall Street analysts forecast IROQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IROQ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast IROQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IROQ is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0
Current: 27.160
0
Current: 27.160
No data
